IFI16 and breast cancer: We previously reported that one of the ISGs, IFN-γ-inducible protein 16 (IFI16), was differentially expressed between ER-positive and ER-negative BCs and that it positively or negatively regulated ER expression depending on the cellular context of the BC [17].